Lantus solostar and Modafinil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lantus solostar (insulin glargine recombinant) and Modafinil (modafinil). Common drug interactions include dizziness among females and arthritis among males.

The phase IV clinical study analyzes what interactions people have when they take Lantus solostar and Modafinil. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Lantus solostar?

Lantus solostar has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 41,639 Lantus solostar users. Check the latest studies of Lantus solostar.

What is Modafinil?

Modafinil has active ingredients of modafinil. It is often used in narcolepsy. eHealthMe is studying from 20,805 Modafinil users. Check the latest studies of Modafinil.



On Jul, 15, 2026

16 people who take Lantus solostar and Modafinil together, and have interactions are studied.

Lantus solostar and Modafinil drug interactions.

What are the common drug interactions of Lantus Solostar and Modafinil, by gender? *:

female:

  1. Dizziness
  2. Dysphonia (speech disorder attributable to a disorder of phonation)
  3. Oropharyngeal pain
  4. Weight decreased
  5. Pneumonia
  6. Abdominal distension
  7. Abdominal pain
  8. Alopecia (absence of hair from areas of the body)
  9. Anaemia (lack of blood)
  10. Ascites (accumulation of fluid in the abdominal cavity)

male:

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Skin fissures (a crack in the skin)
  4. Surgery
  5. Thyroid disorder (thyroid diseases)
  6. Cardiac failure congestive
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Drug ineffective
  9. Hereditary angioedema (recurrent episodes of severe swelling)
  10. Injection site pain

What are the common drug interactions of Lantus Solostar and Modafinil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chest pain
  2. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  3. Cough
  4. Decreased appetite
  5. Dizziness
  6. Dysphonia (speech disorder attributable to a disorder of phonation)
  7. Dyspnoea exertional (breathlessness or shortness of breath)
  8. Flatulence (flatus expelled through the anus)
  9. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  10. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)

50-59:

  1. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  2. Upper respiratory tract infection

60+:

  1. Injection site pain
  2. Pneumonia
  3. Rash macular (small, flat red spots)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 25.00%
  2. Primary Immunodeficiency Syndrome: 2 people, 12.50%
  3. Immunodeficiency Common Variable: 2 people, 12.50%
  4. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 6.25%
  5. Peripheral Vascular Disorder: 1 person, 6.25%
  6. Immune System Disorder: 1 person, 6.25%
  7. High Blood Cholesterol: 1 person, 6.25%
  8. Hereditary Angioedema (recurrent episodes of severe swelling): 1 person, 6.25%
  9. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 1 person, 6.25%
  10. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Lantus solostar and Modafinil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lantus solostar and Modafinil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lantus solostar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Modafinil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lantus solostar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Modafinil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine recombinant and modafinil (the active ingredients of Lantus solostar and Modafinil, respectively), and Lantus solostar and Modafinil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: